Zobrazeno 1 - 10
of 20
pro vyhledávání: '"S. A. Wickline"'
Publikováno v:
European Heart Journal. 43
Introduction Cisplatin, one of the most potent anti-cancer chemotherapy drugs, is still broadly used in first-line chemotherapy regimens, which are subscribed to about 10 to 20% of total cancer patients. Nephrotoxicity is a particularly limiting fact
Publikováno v:
European Heart Journal. 43
Introduction Cisplatin, discovered over 50 years ago, is still one of the most potent anti-cancer chemotherapy drugs and broadly used in first-line chemotherapy regimens subscribed to about 10 to 20% of total cancer patients. However, the full anti-c
Autor:
M W, Thairu, I H, Skidmore, R, Bansal, E, Nováková, T E, Hansen, H, Li-Byarlay, S A, Wickline, A K, Hansen
Publikováno v:
Insect molecular biology. 26(3)
RNA interference (RNAi) has emerged as a promising method for validating gene function; however, its utility in nonmodel insects has proven problematic, with delivery methods being one of the main obstacles. This study investigates a novel method of
Autor:
Thomas F. Budinger, John T. Watson, S. A. Wickline, G. M. Pohost, Roderic I. Pettigrew, Elliot R. McVeigh, A S Berson
Publikováno v:
Radiology. 208:573-576
Publikováno v:
Medicamundi. 54(2)
Autor:
A. K. M. Newaz, W.-J. Chang, K. D. Wallace, S. A. Wickline, R. Bashir, A. M. Gilbertson, L. F. Cohen, L. C. Edge, S. A. Solin, Jisoon Ihm, Hyeonsik Cheong
Publikováno v:
AIP Conference Proceedings.
We report here the observation of inverse extraordinary optoconductance (I‐EOC) in a Ti‐GaAs metal‐semiconductor hybrid (MSH) structure where the photoconductance of the device decreases as the light intensity increases. The artificially design
Publikováno v:
Proceedings of the 20th Annual International Conference of the IEEE Engineering in Medicine and Biology Society. Vol.20 Biomedical Engineering Towards the Year 2000 and Beyond (Cat. No.98CH36286).
Currently, the diagnosis of coronary artery disease is a long, expensive and sometimes invasive process consisting of numerous tests and may include catheterization and hospitalization of patients. The noninvasive nature of a magnetic resonance exami
Autor:
X, Yu, S K, Song, J, Chen, M J, Scott, R J, Fuhrhop, C S, Hall, P J, Gaffney, S A, Wickline, G M, Lanza
Publikováno v:
Magnetic resonance in medicine. 44(6)
In this study, the sensitivity of a novel fibrin-targeted contrast agent for fibrin detection was defined in vitro on human thrombus. The contrast agent was a lipid-encapsulated perfluorocarbon nanoparticle with numerous Gd-DTPA complexes incorporate
Publikováno v:
Journal of magnetic resonance imaging : JMRI. 12(5)
In many cardiac patients, image quality and/or scan efficiency is reduced due to imprecise R-wave ability to trigger the scan due to noise on the electrocardiogram (ECG) caused by the magnetic resonance (MR) environment. We developed a triggering sys
Autor:
S A, Anderson, R K, Rader, W F, Westlin, C, Null, D, Jackson, G M, Lanza, S A, Wickline, J J, Kotyk
Publikováno v:
Magnetic resonance in medicine. 44(3)
Site-directed contrast enhancement of angiogenic vessels in vivo was demonstrated using antibody targeting of an MRI contrast agent to the alpha(v)beta(3) integrin, a molecular marker characteristic of angiogenic endothelium. The agent was tested in